Galiximab (anti-CD80)-induced growth inhibition and prolongation of survival in vivo of B-NHL tumor xenografts and potentiation by the combination with fludarabine

por HARIHARAN, KANDASAMY, CHU, PETER, MURPHY, TRACEY, CLANTON, DANA, BERQUIST, LISA, MOLINA, ARTURO, HO, STEFFAN N., VEGA, MARIO I., BONAVIDA, BENJAMIN
Publicado 2013

Structure of the human marker of self 5-transmembrane receptor CD47

por Fenalti, Gustavo, Villanueva, Nicolas, Griffith, Mark, Pagarigan, Barbra, Lakkaraju, Sirish Kaushik, Huang, Richard Y.-C., Ladygina, Nadia, Sharma, Alok, Mikolon, David, Abbasian, Mahan, Johnson, Jeffrey, Hadjivassiliou, Haralambos, Zhu, Dan, Chamberlain, Philip P., Cho, Ho, Hariharan, Kandasamy
Publicado 2021

Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs

por Zhang, Mingjun, Haughey, Michael, Wang, Nai-Yu, Blease, Kate, Kapoun, Ann M., Couto, Suzana, Belka, Igor, Hoey, Timothy, Groza, Matthew, Hartke, James, Bennett, Brydon, Cain, Jennifer, Gurney, Austin, Benish, Brent, Castiglioni, Paola, Drew, Clifton, Lachowicz, Jean, Carayannopoulos, Leon, Nathan, Steven D., Distler, Jorg, Brenner, David A., Hariharan, Kandasamy, Cho, Ho, Xie, Weilin
Publicado 2020